Brainstorm Cell Therapeutics, Inc. (BCLI)
1.065
-0.06
(-5.19%)
USD |
OTCM |
Aug 31, 16:00
Brainstorm Cell Therapeutics Cash and Short Term Investments (Quarterly) : 0.022M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.022M |
| March 31, 2026 | 0.015M |
| December 31, 2025 | 0.029M |
| September 30, 2025 | 0.005M |
| June 30, 2025 | 0.824M |
| March 31, 2025 | 1.644M |
| December 31, 2024 | 0.187M |
| September 30, 2024 | 0.168M |
| June 30, 2024 | 3.469M |
| March 31, 2024 | 0.779M |
| December 31, 2023 | 1.30M |
| September 30, 2023 | 1.418M |
| June 30, 2023 | 0.748M |
| March 31, 2023 | 2.227M |
| December 31, 2022 | 2.983M |
| September 30, 2022 | 7.393M |
| June 30, 2022 | 12.24M |
| March 31, 2022 | 18.40M |
| December 31, 2021 | 22.09M |
| September 30, 2021 | 27.81M |
| June 30, 2021 | 34.61M |
| March 31, 2021 | 40.05M |
| December 31, 2020 | 41.94M |
| September 30, 2020 | 28.81M |
| June 30, 2020 | 16.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.49M |
| December 31, 2019 | 0.569M |
| September 30, 2019 | 2.129M |
| June 30, 2019 | 2.701M |
| March 31, 2019 | 6.225M |
| December 31, 2018 | 7.064M |
| September 30, 2018 | 10.89M |
| June 30, 2018 | 17.44M |
| March 31, 2018 | 5.605M |
| December 31, 2017 | 7.756M |
| September 30, 2017 | 10.55M |
| June 30, 2017 | 6.717M |
| March 31, 2017 | 8.347M |
| December 31, 2016 | 9.99M |
| September 30, 2016 | 11.19M |
| June 30, 2016 | 11.48M |
| March 31, 2016 | 12.95M |
| December 31, 2015 | 15.96M |
| September 30, 2015 | 17.15M |
| June 30, 2015 | 19.70M |
| March 31, 2015 | 21.35M |
| December 31, 2014 | 8.541M |
| September 30, 2014 | 10.57M |
| June 30, 2014 | 11.33M |
| March 31, 2014 | 3.027M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0562M |
| Summit Therapeutics, Inc. | 691.00M |
| Kezar Life Sciences, Inc. | 66.23M |
| Protara Therapeutics, Inc. | 142.49M |
| Clene, Inc. | 9.671M |